Skip to main content
SpringerLink
Log in

Managing Immunomodulators Perioperatively

  • Chapter
  • First Online:
Mastery of IBD Surgery

Abstract

With the westernization of industrialized societies, the incidence of inflammatory bowel disease (IBD) has drastically increased globally. With this rise in incidence, there has been a resultant rise in the number of patients on immunosuppressive medications [1]. Colorectal surgeons, therefore, must be well prepared for the potential perioperative complications associated with these medications. Immunomodulators (thiopurines, calcineurin inhibitors, and methotrexate) are one class of medication that is used quite frequently in the medical treatment of IBD. Intuitively, as these medications alter immune system function, they raise a theoretical concern of increased perioperative complication rate, particularly related to wound infection, anastomotic healing, and other infectious complications. In this chapter, we examine the literature pertinent to the timing of surgery in patients on immunomodulators and provide our recommendations for the management of these medications in the perioperative period.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390(10114):2769–78.

    Article  Google Scholar 

  2. Aberra FN, Lewis JD, Hass D, Rombeau JL, Osborne B, Lichtenstein GR. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology. 2003;125(2):320–7.

    Article  CAS  Google Scholar 

  3. Bafford AC, Powers S, Ha C, et al. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn’s disease. J Clin Gastroenterol. 2013;47(6):491–5.

    Article  Google Scholar 

  4. Canedo J, Lee SH, Pinto R, Murad-Regadas S, Rosen L, Wexner SD. Surgical resection in Crohn’s disease: is immunosuppressive medication associated with higher postoperative infection rates? Color Dis. 2011;13(11):1294–8.

    Article  CAS  Google Scholar 

  5. Colombel JF, Loftus EV, Tremaine WJ, et al. Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol. 2004;99(5):878–83.

    Article  CAS  Google Scholar 

  6. El-Hussuna A, Andersen J, Bisgaard T, et al. Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn’s disease. Scand J Gastroenterol. 2012;47(6):662–8.

    Article  CAS  Google Scholar 

  7. Indar AA, Young-Fadok TM, Heppell J, Efron JE. Effect of perioperative immunosuppressive medication on early outcome in Crohn’s disease patients. World J Surg. 2009;33(5):1049–52.

    Article  Google Scholar 

  8. Mahadevan U, Loftus EV, Tremaine WJ, et al. Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications. Inflamm Bowel Dis. 2002;8(5):311–6.

    Article  Google Scholar 

  9. Page MJ, Poritz LS, Kunselman SJ, Koltun WA. Factors affecting surgical risk in elderly patients with inflammatory bowel disease. J Gastrointest Surg. 2002;6(4):606–13.

    Article  Google Scholar 

  10. Uchino M, Ikeuchi H, Bando T, et al. Does pre-operative multiple immunosuppressive therapy associate with surgical site infection in surgery for ulcerative colitis. Digestion. 2015;92(3):121–9.

    Article  CAS  Google Scholar 

  11. White EC, Melmed GY, Vasiliauskas E, et al. Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn’s disease? Dis Colon Rectum. 2012;55(5):563–8.

    Article  Google Scholar 

  12. Tay GS, Binion DG, Eastwood D, Otterson MF. Multivariate analysis suggests improved perioperative outcome in Crohn’s disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. Surgery. 2003;134(4):565–72; discussion 572–563

    Article  Google Scholar 

  13. Myrelid P, Olaison G, Sjödahl R, Nyström PO, Almer S, Andersson P. Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn’s disease. Dis Colon Rectum. 2009;52(8):1387–94.

    Article  Google Scholar 

  14. Fleshner PR, Michelassi F, Rubin M, Hanauer SB, Plevy SE, Targan SR. Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin. Dis Colon Rectum. 1995;38(12):1241–5.

    Article  CAS  Google Scholar 

  15. Hyde GM, Jewell DP, Kettlewell MG, Mortensen NJ. Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications. Dis Colon Rectum. 2001;44(10):1436–40.

    Article  CAS  Google Scholar 

  16. Nelson R, Liao C, Fichera A, Rubin DT, Pekow J. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis. Inflamm Bowel Dis. 2014;20(1):14–20.

    Article  Google Scholar 

  17. Pinna-Pintor M, Arese P, Bona R, et al. Severe steroid-unresponsive ulcerative colitis: outcomes of restorative proctocolectomy in patients undergoing cyclosporin treatment. Dis Colon Rectum. 2000;43(5):609–13; discussion 613–604

    Article  CAS  Google Scholar 

  18. Poritz LS, Rowe WA, Swenson BR, Hollenbeak CS, Koltun WA. Intravenous cyclosporine for the treatment of severe steroid refractory ulcerative colitis: what is the cost? Dis Colon Rectum. 2005;48(9):1685–90.

    Article  Google Scholar 

  19. Saito E, Nagahori M, Fujii T, Ohtsuka K, Watanabe M. Efficacy of salvage therapy and its effect on operative outcomes in patients with ulcerative colitis. Digestion. 2014;89(1):55–60.

    Article  Google Scholar 

  20. Afzali A, Park CJ, Zhu K, et al. Preoperative use of methotrexate and the risk of early postoperative complications in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(8):1887–95.

    Article  Google Scholar 

  21. Lightner AL, Shen B. Perioperative use of immunosuppressive medications in patients with Crohn’s disease in the new “biological era”. Gastroenterol Rep (Oxf). 2017;5(3):165–77.

    Article  Google Scholar 

  22. Myrelid P, Svärm S, Andersson P, Almer S, Bodemar G, Olaison G. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn’s disease. Scand J Gastroenterol. 2006;41(10):1190–5.

    Article  CAS  Google Scholar 

  23. Peyrin-Biroulet L, Deltenre P, Ardizzone S, et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. Am J Gastroenterol. 2009;104(8):2089–96.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cleveland Clinic, Cleveland, OH, USA

    David R. Rosen

  2. Washington University at St. Louis, St. Louis, MO, USA

    Radhika K. Smith

Authors
  1. David R. Rosen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Radhika K. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Colon and Rectal Surgery, University of Chicago, Chicago, IL, USA

    Neil Hyman

  2. Section of Colon and Rectal Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Phillip Fleshner

  3. Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

    Scott Strong

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rosen, D.R., Smith, R.K. (2019). Managing Immunomodulators Perioperatively. In: Hyman, N., Fleshner, P., Strong, S. (eds) Mastery of IBD Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-16755-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-16755-4_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-16754-7

  • Online ISBN: 978-3-030-16755-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation